Recombinant Human RBBP9 Protein，His

RBBP9, or Retinoblastoma Binding Protein 9, is a crucial player in various cellular processes, including cell cycle regulation, apoptosis, and transcriptional control. Its role in the regulation of gene expression and interaction with the retinoblastoma (Rb) tumor suppressor protein makes it a significant focus of cancer research, particularly in the context of tumors where Rb pathway is disrupted. Studies have shown that dysregulation of RBBP9 is associated with several types of malignancies, highlighting its potential as a biomarker for cancer diagnosis and prognosis. Additionally, RBBP9 functions within diverse molecular complexes, influencing chromatin remodeling and the modifications of histones, which are pivotal for understanding epigenetic regulation in cancer. The recombinant expression of RBBP9 allows researchers to investigate its structural and functional properties in greater detail, paving the way for potential therapeutic interventions. By developing RBBP9 as a recombinant protein, scientists can explore its interactions with other proteins and small molecules, which could lead to the identification of novel targets for cancer treatment. Overall, RBBP9 represents a compelling subject of study within the broader landscape of tumor biology and therapeutic development, necessitating further investigation into its mechanistic roles and applications in oncology.